The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: A phase 3 randomized study of low-dose intralesional cemiplimab versus primary surgery for patients with early-stage cutaneous squamous cell carcinoma (CLEAR CSCC).
 
Michael Migden
Honoraria - Regeneron
Consulting or Advisory Role - Feldan Therapeutics; Replimune; Stamford Pharmaceuticals
Research Funding - Regeneron (Inst)
Travel, Accommodations, Expenses - Regeneron
 
Sherrif Ibrahim
Consulting or Advisory Role - Regeneron
Speakers' Bureau - Regeneron Pharmaceuticals, Inc., Castle Biosciences
Research Funding - Regeneron Pharmaceuticals, Inc., Replimune, Castle Biosciences
 
John Strasswimmer
Consulting or Advisory Role - Regeneron
Speakers' Bureau - Regeneron Pharmaceuticals, Inc., Sanofi, Genentech
Research Funding - Biofrontera, Regeneron Pharmaceuticals, Inc.
Travel, Accommodations, Expenses - Regeneron Pharmaceuticals, Inc., Sanofi
 
Nathalie Zeitouni
Consulting or Advisory Role - Sun Pharma, Biofrontera
Speakers' Bureau - Castle Biosciences; Regeneron
Research Funding - Replimune, Sun Pharma, Biofrontera, Castle Biosciences, Dermasensor, Regeneron Pharmaceuticals, Inc.
 
Suk-Young Yoo
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Frank Seebach
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Israel Lowy
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron
 
Mihaela Cristea
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Matthew Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Research Funding - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneorn; Regeneron (I)